Cargando…

IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats

BACKGROUND: Intestinal barrier dysfunction is not only the consequence of liver cirrhosis, but also an active participant in the development of liver cirrhosis. Previous studies showed that external administration of insulin-like growth factor 1 (IGF-1) improved intestinal barrier function in liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Tian-Yu, Su, Li-Ping, Ma, Chun-Ye, Zhai, Xiao-Han, Duan, Zhi-Jun, Zhu, Ying, Zhao, Gang, Li, Chun-Yan, Wang, Li-Xia, Yang, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495682/ https://www.ncbi.nlm.nih.gov/pubmed/26152281 http://dx.doi.org/10.1186/s12876-015-0311-5

Ejemplares similares

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

Management of Portal Vein Thrombosis in Cirrhotic Patients
por: Amitrano, Lucio, et al.
Publicado: (2009)

Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction
por: Artru, Florent, et al.
Publicado: (2022)

Portal vein thrombosis leading to pre-sinusoidal non-cirrhotic portal hypertension resulting in decreased synthetic function of the liver
por: Kline, Kevin, et al.
Publicado: (2019)

Non-cirrhotic portal vein thrombosis – therapeutic challenge
por: Sarquis, Lucas Mansano, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
por: Yan, Xuan-Hui, et al.
Publicado: (2022)

Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction
por: Zhou, Yongjie, et al.
Publicado: (2023)

Metastases can occur in cirrhotic livers with patent portal veins
por: Mahdi, Zaid, et al.
Publicado: (2021)

Association Between Portal Vein Color Doppler Findings and the Severity of Disease in Cirrhotic Patients With Portal Hypertension
por: Mittal, Puneet, et al.
Publicado: (2011)

Superior Mesenteric Vein Aneurysm With Arteriovenous Communication and Portal Vein Thrombosis: A Rare Presentation in Non-cirrhotic Portal Hypertension
por: Nitesh, Pagadala, et al.
Publicado: (2023)

Nomogram for Predicting Portal Vein Thrombosis in Cirrhotic Patients: A Retrospective Cohort Study
por: Ding, Jingnuo, et al.
Publicado: (2023)

Natural Course of Nonmalignant Partial Portal Vein Thrombosis in Cirrhotic Patients
por: Girleanu, Irina, et al.
Publicado: (2014)

Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients
por: Zhang, Zhi-Hao, et al.
Publicado: (2017)

Obesity is not associated with an increased risk of portal vein thrombosis in cirrhotic patients
por: Zakko, Alan, et al.
Publicado: (2018)

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
por: Hung, Hao-Chien, et al.
Publicado: (2020)

Coexisting giant splenic artery and portal vein aneurysms leading to non-cirrhotic portal hypertension: a case report
por: Khan, Abidullah, et al.
Publicado: (2016)

Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats
por: Pun, Chon Kit, et al.
Publicado: (2021)

Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis
por: Kukla, Michał, et al.
Publicado: (2017)

COVID-19 in Cirrhotic Patients: Is Portal Vein Thrombosis a Potential Complication?
por: Hassnine, Alshymaa A, et al.
Publicado: (2022)

Diagnostic Accuracy of Portal Vein Flow Velocity for Esophageal Varices in Cirrhotic Patients
por: Wasif Khan, Hafiz Muhammad, et al.
Publicado: (2023)

The beneficial effects of curcumin in cirrhotic rats with portal hypertension
por: Hsu, Shao-Jung, et al.
Publicado: (2017)

Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review
por: Gupta, Sachin, et al.
Publicado: (2021)

Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein
por: Li, Weixiao, et al.
Publicado: (2023)

Anomalous duplication of the portal vein with prepancreatic postduodenal portal vein
por: Kitagawa, Sho
Publicado: (2022)

In the non-cirrhotic stage of nonalcoholic steatohepatitis, angioarchitecture of portal veins and lobular architecture are maintained
por: Hano, Hiroshi, et al.
Publicado: (2013)

Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture
por: Gîrleanu, Irina, et al.
Publicado: (2018)

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
por: Biolato, Marco, et al.
Publicado: (2022)

The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis
por: Zhang, Zhiqi, et al.
Publicado: (2022)

Combined Hepatic Vein, Umbilicoportal Vein, and Superior Mesenteric Artery Catheterization in Portal Hypertension: Estimation of the Portal Fraction of Total Hepatic Blood Flow in Cirrhotic Patients
por: Huet, P. M., et al.
Publicado: (1975)

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension
por: Biecker, Erwin
Publicado: (2013)

Causes and Management of Non-cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2020)

Innovative angiography: a new approach to discover more hepatic vein collaterals in patients with cirrhotic portal hypertension
por: Liu, Bowen, et al.
Publicado: (2023)

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension
por: Saeki, Michio, et al.
Publicado: (2023)

Establishment and verification a nomogram for predicting portal vein thrombosis presence among admitted cirrhotic patients
por: Liu, Guang-hua, et al.
Publicado: (2023)

Assessment of intrahepatic blood flow by Doppler ultrasonography: Relationship between the hepatic vein, portal vein, hepatic artery and portal pressure measured intraoperatively in patients with portal hypertension
por: Zhang, Li, et al.
Publicado: (2011)

Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis
por: Dong, Gang, et al.
Publicado: (2021)

Effect of portal vein ligation on tumor growth and liver regeneration in rat cirrhotic liver lobes
por: XU, RUI, et al.
Publicado: (2014)

Pregnancy in the Setting of Asymptomatic Non-Cirrhotic Chronic Portal Vein Thrombosis Complicated by Pre-Eclampsia
por: Üstüner, Işık, et al.
Publicado: (2013)

Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes?
por: Licinio, Raffaele, et al.
Publicado: (2014)

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients
por: Zampino, Rosa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lj6d5msnhos69va5e85o5qjvap